Q3 2011

Source filing unavailable

Q3 2011 · —

Revenue

$202.19M

+8.3% vs Q3 2010

Net Income

$11.24M

−31.8% vs Q3 2010

EPS Diluted

$0.39

−29.1% vs Q3 2010

Gross Profit$123,534,000+5.2%

Operating Income$18,291,000−33.0%

Operating Cash Flowderived

Same quarter

Metric	Q3 2011	Q3 2010	Q3 2009
Revenue	$202.19M	$186.64M	$172.29M
Net Income	$11.24M	$16.48M	$14.43M
EPS Diluted	$0.39	$0.55	$0.49

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR